Overview

What is multiple sclerosis? An expert explains

Learn more from neurologist Oliver TobinM.B.B.Ch.B.A.O.Ph.D.

I'm Dr. Oliver Tobina neurologist specializing in multiple sclerosis at Mayo Clinic. In this videowe'll be covering the basics of multiple sclerosis. What is it? Who gets it? The symptomsdiagnosisand treatment. Whether you're looking for answers about your own health or that of someone you lovewe're here to provide you with the best information available. Multiple sclerosis is a disorder in which the body's immune system attacks the protective covering of the nerve cells in the brainoptic nerve and spinal cordcalled the myelin sheath. And this sheath is often compared to the insulation on an electrical wire. When that covering is damagedit exposes the actual nerve fiberwhich can slow or block the signals being transmitted within it. The nerve fibers themselves might also be damaged. The body can repair damage to the myelin sheathbut it's not perfect. The resulting damage leaves lesions or scarsand this is where the name comes from: multiple sclerosismultiple scars. Now everyone loses brain cells and spinal cord cells as they get older. But if part of the brain or spinal cord has been damaged by MSthe nerve cells in that area will die off faster than the areas around it that are normal. This happens very slowlyusually over decades and typically shows up as gradual walking difficulty happening over several years. When you read about multiple sclerosisyou may hear about different types -- the most frequent being relapsing-remitting multiple sclerosis. And this is characterized by attacksor relapses.

We don't know what causes MSbut there are certain factors that may increase the risk or trigger its onset. So while MS can occur at any ageit mostly makes its first appearance in people between the ages of 20 and 40. Low levels of vitamin D and low exposure to sunlightwhich enables our body to make vitamin Dare associated with an increased risk of developing MS. As people who have MS who have low vitamin D tend to have more severe disease. So people who are overweight are more likely to develop MS and people who have MS and are overweight tend to have more severe disease and a faster onset of progression. People who have MS and who smoke tend to have more relapsesworse progressive diseaseand worse cognitive symptoms. Women are up to three times as likely as men to have relapsing-remitting MS. The risk for MS in the general population is about 0.5%. If a parent or sibling has MSyour risk is about twice that or about 1%. Certain infections are also important. A variety of viruses have been linked to MSincluding Epstein-Barr viruswhich causes mono. Northern and southern latitudes have a higher prevalenceincluding Canadathe northern USNew Zealandsoutheastern Australiaand Europe. White peopleespecially of northern European descentare at the highest risk. People of AsianAfricanand Native American ancestry have the lowest risk. A slightly increased risk is seen if a patient already has autoimmune thyroid diseasepernicious anemiapsoriasistype 1 diabetesor inflammatory bowel disease.

Symptoms of a relapse usually come on over 24 to 48 hourslast for a few days to a few weeks and then improve in the region of 80 to a 100 percent. Those symptoms include loss of vision in an eyeloss of power in an arm or leg or a rising sense of numbness in the legs. Other common symptoms associated with MS include spasmsfatiguedepressionincontinence issuessexual dysfunctionand walking difficulties.

There's currently no single test to make a diagnosis of MS. Howeverthere are four key features which help to secure the diagnosis. Firstlyare there typical symptoms of multiple sclerosis? Againthose are loss of vision in an eyeloss of power in an arm or legor sensory disturbance in an arm or leg lasting for more than 24 hours. Secondlydo you have any physical examination findings consistent with MS? Nextis the MRI of your brain or spine consistent with MS? Now here it's important to note that 95 percent of people over the age of 40 have an abnormal brain MRIjust the same as many of us have wrinkles on our skin. Lastlyare the results of the spinal fluid analysis consistent with MS? Your doctor may recommend blood tests to check for other diseases that share the same symptoms. They may also recommend an OCT test or optical coherence tomography. This is a short scan of the thickness of the layers at the back of your eye.

So the best thing to do when living with MS is to find a trusted interdisciplinary medical team that can help you monitor and manage your health. Having a multidisciplinary team is essential for addressing the individual symptoms that you're experiencing. If you have an MS attack or relapseyour doctor may prescribe you corticosteroids to reduce or improve your symptoms. And if your attack symptoms do not respond to steroidsanother option is plasmapheresis or plasma exchangewhich is a treatment similar to dialysis. About 50 percent of people who do not respond to steroids have a significant improvement with a short course of plasma exchange. There are over 20 medications currently approved for prevention of MS attacks and prevention of new MRI lesions.

As learning to function with MS can be challengingthere are medical experts ready to work with you to help you manage itso you can still live a full life. Consulting with a physiatristphysical or occupational therapist can help you deal with physical difficulties. Physical activity is strongly recommended for all people with MS. Mental health is also an important consideration. So keeping up personal connections with friends and family and trying to stay involved with your hobbies is important. But also be kind to yourself and realistic about what you're up for. This can change from day to dayso it's okay to give yourself permission if something seems like too much or if you need to cancel plans. You may also find support groups helpful to connect with people who understand what you are going through and discuss your feelings and concerns with a doctor or a counselor. Meanwhilescientists are hard at workexpanding our understanding of this disease and developing new treatments and medications which are ever more effective. If you want to learn morewatch more of our videos or visit mayoclinic.org. We wish you well.

Multiple sclerosis is a disease that causes breakdown of the protective covering of nerves. Multiple sclerosis can cause numbnessweaknesstrouble walkingvision changes and other symptoms. It's also known as MS.

In MSthe immune system attacks the protective sheath that covers nerve fibersknown as myelin. This interrupts communication between the brain and the rest of the body. Eventuallythe disease can cause permanent damage of the nerve fibers.

Symptoms of MS depend on the personthe location of damage in the nervous system and how bad the damage is to the nerve fibers. Some people lose the ability to walk on their own or move at all. Others may have long periods between attacks without any new symptomscalled remission. The course of the disease varies depending on the type of MS.

There's no cure for multiple sclerosis. Howeverthere are treatments to help speed the recovery from attacksmodify the course of the disease and manage symptoms.

Types

Some conditions are classified as stagesbut multiple sclerosis is classified as types. MS types depend on the progression of symptoms and frequency of relapses. Types of MS include:

Relapsing-remitting MS

Most people with multiple sclerosis have the relapsing-remitting type. They experience periods of new symptoms or relapses that develop over days or weeks and usually improve partially or completely. These relapses are followed by quiet periods of disease remission that can last months or even years.

Secondary-progressive MS

At least 20% to 40% of people with relapsing-remitting multiple sclerosis can eventually develop a steady progression of symptoms. This progression may come with or without periods of remission and happens within 10 to 40 years of disease onset. This is known as secondary-progressive MS.

The worsening of symptoms usually includes trouble with mobility and walking. The rate of disease progression varies greatly among people with secondary-progressive MS.

Primary-progressive MS

Some people with multiple sclerosis experience a gradual onset and steady progression of signs and symptoms without any relapses. This type of MS is known as primary-progressive MS.

Clinically isolated syndrome

Clinically isolated syndrome refers to the first episode of a condition that affects the myelin. After further testingclinically isolated syndrome may be diagnosed as MS or a different condition.

Radiologically isolated syndrome

Radiologically isolated syndrome refers to findings on MRIs of the brain and spinal cord that look like MS in someone without classic symptoms of MS.

Symptoms

Multiple sclerosis symptoms vary depending on the person. Symptoms may change over the course of the disease depending on which nerve fibers are affected.

Common symptoms include:

  • Numbness or tingling.
  • Electric-shock sensations that happen with certain neck movementsespecially bending the neck forward. This sensation is called Lhermitte sign.
  • Lack of coordination.
  • Trouble with walking or not being able to walk at all.
  • Weakness.
  • Partial or complete loss of visionusually in one eye at a time. Vision loss often happens with pain during eye movement.
  • Double vision.
  • Blurry vision.
  • Dizziness and a false sense that you or your surroundings are movingknown as vertigo.
  • Trouble with sexualbowel and bladder function.
  • Fatigue.
  • Slurred speech.
  • Troubles with memorythinking and understanding information.
  • Mood changes.

Small increases in body temperature can temporarily worsen symptoms of MS. These aren't considered true disease relapses but pseudorelapses.

When to see a doctor

Make an appointment with your doctor or other healthcare professional if you have any symptoms that worry you.

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancementshealth tipscurrent health topicsand expertise on managing health. Click here for an email preview.

We use the data you provide to deliver you the content you requested. To provide you with the most relevant and helpful informationwe may combine your email and website data with other information we have about you. If you are a Mayo Clinic patientwe will only use your protected health information as outlined in our Notice of Privacy Practices. You may opt out of email communications at any time by clicking on the unsubscribe link in the email.

Causes

The cause of multiple sclerosis is not known. It's considered an immune-mediated disease in which the body's immune system attacks its own tissues. In MSthe immune system attacks and destroys the fatty substance that coats and protects nerve fibers in the brain and spinal cord. This fatty substance is called myelin.

Myelin can be compared to the insulation coating on electrical wires. When the protective myelin is damaged and the nerve fiber is exposedthe messages traveling along that nerve fiber may be slowed or blocked.

It isn't clear why MS develops in some people and not others. A combination of genetics and environmental factors may increase the risk of MS.

Risk factors

Factors that increase the risk of multiple sclerosis include:

  • Age. MS can happen at any age. Howeveronset most commonly happens between 20 and 40 years of age.
  • Sex. Women are 2 to 3 times more likely than men to have relapsing-remitting MS.
  • Family history. If one of your parents or siblings has had MSyou are at higher risk of developing the disease.
  • Certain infections. A variety of viruses have been linked to MSincluding Epstein-Barr. Epstein-Barr is the virus that causes infectious mononucleosis.
  • Race. People with white skinparticularly those of Northern European descenthave the highest risk of developing MS. People of AsianAfrican or Native American descent have the lowest risk. A recent study suggests that the number of Black and Hispanic young adults with multiple sclerosis may be greater than previously thought.
  • Climate. MS is far more common in places with temperate climates. These include Canadathe northern United StatesNew Zealandsoutheastern Australia and Europe.
  • Vitamin D. Having low levels of vitamin D and low exposure to sunlight is linked to a greater risk of MS. Your birth month also may affect the chances of developing MS. This has to do with levels of sun exposure when a mother is pregnant.
  • Obesity. People who are obese or were obese in childhood have an increased risk of multiple sclerosis.
  • Certain autoimmune diseases. You have a slightly higher risk of developing MS if you have other autoimmune conditions. These may include thyroid diseasepernicious anemiapsoriasistype 1 diabetes or inflammatory bowel disease.
  • Smoking. People who smoke have a higher risk of relapsing-remitting MS than people who don't smoke.
  • Gut microbiome. People with MS may have a different gut microbiome than people who don't have MS. More research is needed to understand this connection.

Complications

Complications of multiple sclerosis may include:

  • Mood changessuch as depressionanxiety or mood swings.
  • Muscle stiffness or spasms.
  • Seizuresthough they are very rare.
  • Severe weakness or paralysistypically in the arms or legs.
  • Trouble with bladderbowel or sexual function.
  • Trouble with thinking and memory.
Nov. 012024
  1. What is multiple sclerosis? National Multiple Sclerosis Society. https://www.nationalmssociety.org/What-is-MS. Accessed June 102024.
  2. Clinical overview: Multiple sclerosis. Elsevier Point of Care. 2023. https://www.clinicalkey.com. Accessed June 192024.
  3. Olek MJet al. Clinical presentationcourseand prognosis of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 192024.
  4. Olek MJet al. Pathogenesis and epidemiology of multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 192024.
  5. Olek MJet al. Evaluation and diagnosis of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 192024.
  6. Olek MJet al. Treatment of acute exacerbations of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 192024.
  7. Olek MJet al. Initial disease-modifying therapy for relapsing-remitting multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 192024.
  8. Olek MJet al. Clinical use of monoclonal antibody disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 192024.
  9. Olek MJet al. Clinical use of oral disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 192024.
  10. Olek MJet al. Symptom management of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 192024.
  11. Olek MJet al. Overview of disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 192024.
  12. Olek MJet al. Manifestations of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 192024.
  13. Jankovic Jet al.eds. Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. In: Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed June 192024.
  14. Pizzorno JEet al.eds. Multiple sclerosis. In: Textbook of Natural Medicine. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed June 192024.
  15. Krämer Jet al. Bruton tyrosine kinase inhibitors for multiple sclerosis. Nature Reviews Neurology. 2023; doi:10.1038/s41582-023-00800-7.
  16. Pediatric MS. National Multiple Sclerosis Society. https://www.nationalmssociety.org/for-professionals/for-healthcare-professionals/managing-and-treating-ms/pediatric-ms. Accessed June 192024.
  17. Multiple sclerosis. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/multiple-sclerosis#. Accessed June 242024.
  18. Saadeh RSet al. CSF kappa free light chains: Cutoff validation for diagnosing multiple sclerosis. Mayo Clinic Proceedings. 2022; doi:10.1016/j.mayocp.2021.09.014.
  19. Nimmagadda R. Allscripts EPSi. Mayo Clinic. May 132024.
  20. Deb C. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLOS One. 2010; doi:101371/journal.pone.0012478.
  21. Fadul CEet al. Safety and immune effects of blocking CD40 ligand in multiple sclerosis. Neurology Journals. 2021; doi:10.1212/NXI.0000000000001096.
  22. Nakamura Ket al. Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis. Multiple Sclerosis Journal. 2024; doi:10.1177/13524585231224702.
  23. Katz Sand Iet al. Mediterranean diet is linked to less objective disability in multiple sclerosis. Multiple Sclerosis Journal. 2023; doi:10.1177/13524585221127414.
  24. Kantarci OHet al. Novel immunomodulatory approaches for the management of multiple sclerosis. Clinical Pharmacology & Therapeutics. 2014; doi:10.1038/clpt.2013.196.
  25. Winn HRed. Neuropsychological testing. In: Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Oct. 212024.
  26. Hancock LMet al. Neuropsychological manifestations of multiple sclerosis. Neurologic Clinics. 2024; doi:10.1016/j.ncl.2024.05.010.